Atlas Trials

Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy

Clinical trial NCT05782933 · UNKNOWN

Trial details

NCT number
NCT05782933
Sponsor
Beijing Friendship Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Idiopathic Membranous Nephropathy
Start date
2022-08-04
Primary completion
2023-12-04
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.